# FDA 483 - Liuzhou LMZ Co., Ltd. - July 05, 2019

Source: https://www.keypedia.com/records/483/liuzhou-lmz-co-ltd/18c3ec4b-eb45-480d-b529-85d23b047fbd

> FDA 483 for Liuzhou LMZ Co., Ltd. on July 05, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Liuzhou LMZ Co., Ltd.
- Inspection Date: 2019-07-05
- Product Type: drugs
- Office Name: Division of Human and Animal Food East V Compliance Branch
- Summary: An FDA inspection of Liuzhou LMZ Co., Ltd., an OTC drug manufacturer in Liuzhou, Guangxi, China, from July 1-5, 2019, revealed significant deficiencies. The firm failed to establish and follow written procedures for manufacturing and quality control, exhibited inadequate laboratory controls and testing method verification, and maintained deficient records. These issues indicate a lack of adherence to good manufacturing practices.

## Related Officers

- [Principal Consultant](https://www.keypedia.com/people/zhongren-wu/416f09a6-f225-4d23-a305-34f96a5c78f0)

Company: https://www.keypedia.com/companies/liuzhou-lmz-co-ltd/3b1d4aaa-cd09-48d7-88f0-257b3fcb719b

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-east-v-compliance-branch/00f6013b-7c92-4daf-ae51-d47ab44bf1cb